Potential impact of cardiac dose-volume on acute cardiac toxicity following concurrent trastuzumab and radiotherapy

Cancer/Radiotherapie

Volumn 18, Issue 2, 2014, Pages 119-124

  Cao, L ^a,b   Hu, W G ^a,b   Kirova, Y M ^c   Yang, Z Z ^a,b   Cai, G ^a,b   Yu, X L ^a,b   Ma, J L ^a,b   Guo, X M ^a,b   Shao, Z M ^a   Chen, J Y ^a,b  

^a FUDAN UNIVERSITY SHANGHAI CANCER CENTER   (China)

^b FUDAN UNIVERSITY   (China)

^c INSTITUT CURIE   (France)

Author keywords

Breast cancer; Cardiac toxicity; Concurrent trastuzumab; Radiation therapy

Indexed keywords

CARBOPLATIN; DOCETAXEL; EPIDERMAL GROWTH FACTOR RECEPTOR 2; EPIRUBICIN; TAXANE DERIVATIVE; TRASTUZUMAB;

ACUTE TOXICITY; ADJUVANT CHEMOTHERAPY; ADJUVANT THERAPY; ADULT; AGED; ARTICLE; BREAST CANCER; CANCER RADIOTHERAPY; CARDIOTOXICITY; DOSIMETRY; FOLLOW UP; HEART FUNCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HORMONAL THERAPY; HUMAN; INTENSITY MODULATED RADIATION THERAPY; LIVER DYSFUNCTION; MAJOR CLINICAL STUDY; MASTECTOMY; MIDDLE AGED; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RADIATION INJURY; RISK ASSESSMENT;

BREAST CANCER; CANCER DU SEIN; CARDIAC TOXICITY; CONCURRENT TRASTUZUMAB; RADIATION THERAPY; RADIOTHÉRAPIE; TOXICITÉ CARDIAQUE; TRASTUZUMAB CONCOMITANT;

ADULT; AGED; ANTIBODIES, MONOCLONAL, HUMANIZED; ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; CHEMOTHERAPY, ADJUVANT; FEMALE; FOLLOW-UP STUDIES; HUMANS; MIDDLE AGED; RADIOTHERAPY DOSAGE; RADIOTHERAPY, ADJUVANT; RADIOTHERAPY, INTENSITY-MODULATED; RECEPTOR, ERBB-2; RETROSPECTIVE STUDIES; RISK FACTORS; STROKE VOLUME; TOMOGRAPHY, X-RAY COMPUTED; VENTRICULAR FUNCTION, LEFT;

EID: 84897108319     PISSN: 12783218     EISSN: 17696658     Source Type: Journal    
DOI: 10.1016/j.canrad.2014.01.001     Document Type: Article

References (30)

1. Clarke M., Collins R., Darby S., Davies C., Elphinstone P., Evans E., et al. Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials. Lancet 2005, 366:2087-2106.
2. Piccart-Gebhart M.J., Procter M., Leyland-Jones B., Goldhirsch A., Untch M., Smith I., et al. Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer. N Engl J Med 2005, 353:1659-1672.
3. Viani G.A., Afonso S.L., Stefano E.J., De Fendi L.I., Soares F.V. Adjuvant trastuzumab in the treatment of her-2-positive early breast cancer: a meta-analysis of published randomized trials. BMC Cancer 2007, 7:153.
4. Chargari C., Kirov K.M., Bollet M.A., Magné N., Védrine L., Cremades S., et al. Cardiac toxicity in breast cancer patients: from a fractional point of view to a global assessment. Cancer Treat Rev 2011, 37:321-330.
5. Darby S.C., Ewertz M., McGale P., Bennet A.M., Blom-Goldman U., Bronnum D., et al. Risk of ischemic heart disease in women after radiotherapy for breast cancer. N Engl J Med 2013, 368:987-998.
6. Kestin L.L., Sharpe M.B., Frazier R.C., Vicini F.A., Yan D., Matter R.C., et al. Intensity modulation to improve dose uniformity with tangential breast radiotherapy: initial clinical experience. Int J Radiat Oncol Biol Phys 2000, 48:1559-1568.
7. Hui G., Jian-rong D., Ye-xiong L.I., Ke Z., Lu-hua W. A simplified intensity modulated radiation therapy technique for difficult clinical cancer condition. Chin J Radiat Oncol 2006, 15:411-415.
8. White J., Tai A., Arthur D., Buchholz T., MacDonald S., Marks L., et al. Breast cancer contouring atlas 2012, Radiation Therapy Oncology Group (RTOG), Philadelphia, RA. http://www.rtog.org/CoreLab/ContouringAtlases/BreastCancerAtlas.aspx.
9. Feng M., Moran J.M., Koelling T., Chughtai A., Chan J.L., Freedman L., et al. Development and validation of a heart atlas to study cardiac exposure to radiation following treatment for breast cancer. Int J Radiat Oncol Biol Phys 2011, 79:10-18.
10. Magné N., Védrine L., Chargari C. Impact on cardiac toxicity with trastuzumab and radiotherapy: the question is still ongoing. J Clin Oncol 2009, 27:e239-e241.
11. Taylor C.W., McGale P., Povall J.M., Thomas E., Kumar S., Dodwell D., et al. Estimating cardiac exposure from breast cancer radiotherapy in clinical practice. Int J Radiat Oncol Biol Phys 2009, 73:1061-1068.
12. Caussa L., Kirova Y.M., Gault N., Pierga J.Y., Savignoni A., Campana F., et al. The acute skin and heart toxicity of a concurrent association of trastuzumab and locoregional breast radiotherapy including internal mammary chain: a single-institution study. Eur J Cancer 2011, 47:65-73.
13. Kirova Y.M., Campana F., Fournier-Bidoz N., Stilhart A., Dendale R., Bollet M.A., et al. Postmastectomy electron beam chest wall irradiation in women with breast cancer: a clinical step toward conformal electron therapy. Int J Radiat Oncol Biol Phys 2007, 69:1139-1144.
14. de Almeida C.E., Fournier-Bidoz N., Massabeau C., Mazal A., Canary P.C., Kuroki I.R., et al. Potential benefits of using cardiac gated images to reduce the dose to the left anterior descending coronary during radiotherapy of left breast and internal mammary nodes. Cancer Radiother 2012, 16:44-51.
15. Jacob J., Belin L., Gobillion A., Daveau-Bergerault C., Dendale R., Beuzeboc P., et al. [Prospective monocentric study of the toxicity and the efficacy of concurrent trastuzumab to radiotherapy]. Cancer Radiother 2013, 17-183.
16. Taylor C.W., Povall J.M., McGale P., Nisbet A., Dodwell D., Smith J.T., et al. Cardiac dose from tangential breast cancer radiotherapy in the year 2006. Int J Radiat Oncol Biol Phys 2008, 72:501-507.
17. Beckham W.A., Popescu C.C., Patenaude V.V., Wai E.S., Olivotto I.A. Is multibeam IMRT better than standard treatment for patients with left-sided breast cancer?. Int J Radiat Oncol Biol Phys 2007, 69:918-924.
18. Lohr F., El-Haddad M., Dobler B., Grau R., Wertz H.J., Kraus-Tiefenbacher U., et al. Potential effect of robust and simple IMRT approach for left-sided breast cancer on cardiac mortality. Int J Radiat Oncol Biol Phys 2009, 74:73-80.
19. Preston D.L., Shimizu Y., Pierce D.A., Suyama A., Mabuchi K. Studies of mortality of atomic bomb survivors. Report 13: Solid cancer and noncancer disease mortality: 1950-1997. Radiat Res 2003, 160:381-407.
20. Gagliardi G., Constine L.S., Moiseenko V., Correa C., Pierce L.J., Allen A.M., et al. Radiation dose-volume effects in the heart. Int J Radiat Oncol Biol Phys 2010, 76:S77-S85.
21. Zambetti M., Moliterni A., Materazzo C., Stefanelli M., Cipriani S., Valagussa P., et al. Long-term cardiac sequelae in operable breast cancer patients given adjuvant chemotherapy with or without doxorubicin and breast irradiation. J Clin Oncol 2001, 19:37-43.
22. Suter T.M., Procter M., van Veldhuisen D.J., Muscholl M., Bergh J., Carlomagno C., et al. Trastuzumab-associated cardiac adverse effects in the herceptin adjuvant trial. J Clin Oncol 2007, 25:3859-3865.
23. Hooning M.J., Aleman B.M., van Rosmalen A.J., Kuenen M.A., Klijn J.G., van Leeuwen F.E. Cause-specific mortality in long-term survivors of breast cancer: A 25-year follow-up study. Int J Radiat Oncol Biol Phys 2006, 64:1081-1091.
24. Nixon A.J., Manola J., Gelman R., Bornstein B., Abner A., Hetelekidis S., et al. No long-term increase in cardiac-related mortality after breast-conserving surgery and radiation therapy using modern techniques. J Clin Oncol 1998, 16:1374-1379.
25. Schultz-Hector S., Trott K.R. Radiation-induced cardiovascular diseases: is the epidemiologic evidence compatible with the radiobiologic data?. Int J Radiat Oncol Biol Phys 2007, 67:10-18.
26. Belkacemi Y., Gligorov J., Ozsahin M., Marsiglia H., De Lafontan B., Laharie-Mineur H., et al. Concurrent trastuzumab with adjuvant radiotherapy in HER2-positive breast cancer patients: acute toxicity analyses from the French multicentric study. Ann Oncol 2008, 19:1110-1116.
27. Tarantini L., Cioffi G., Gori S., Tuccia F., Boccardi L., Bovelli D., et al. Trastuzumab adjuvant chemotherapy and cardiotoxicity in real-world women with breast cancer. J Card Fail 2012, 18:113-119.
28. Ewer M.S., Lenihan D.J. Left ventricular ejection fraction and cardiotoxicity: is our ear really to the ground?. J Clin Oncol 2008, 26:1201-1203.
29. Shah A.M., Solomon S.D. Myocardial deformation imaging: current status and future directions. Circulation 2012, 125:e244-e248.
30. Khouri M.G., Douglas P.S., Mackey J.R., Martin M., Scott J.M., Scherrer-Crosbie M., et al. Cancer therapy-induced cardiac toxicity in early breast cancer: addressing the unresolved issues. Circulation 2012, 126:2749-2763.